Skip to content

Dacomitinib Anhydrous

Published: July 26, 2026Updated: August 25, 2026

Dacomitinib Anhydrous is a second-generation, irreversible pan-epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used to treat certain types of non-small cell lung cancer (NSCLC). It works by permanently binding to EGFR receptors on cancer cells, blocking signals that promote tumor growth and survival. This medication is specifically indicated for patients with NSCLC harboring EGFR mutations.

Quick summary

Dacomitinib is an EGFR inhibitor used to treat EGFR-mutated non-small cell lung cancer by blocking cancer cell growth signals.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

RxNorm
2058848
Generic
Dacomitinib Anhydrous
Class
pin-variant
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of metastatic non-small cell lung cancer (NSCLC) in patients with EGFR mutations (exon 19 deletion or L858R substitution mutations)

As an irreversible EGFR tyrosine kinase inhibitor, dacomitinib covalently binds to and inhibits EGFR receptor signaling, preventing downstream pathways that drive cancer cell proliferation, survival, and metastasis

Common adverse effects include diarrhea, skin rash, nail disorders, and stomatitis. Interstitial lung disease and hepatotoxicity are serious but less common risks. Requires confirmed EGFR mutation status prior to treatment initiation. May interact with CYP3A4 inducers/inhibitors.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy